Susquehanna International Group’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-229
| Closed | -$26.3K | – | 7232 |
|
|
2024
Q4 | $26.3K | Buy |
+229
| New | +$26.3K | ﹤0.01% | 5971 |
|
|
2024
Q1 | – | Sell |
-20
| Closed | -$15.6K | – | 6764 |
|
|
2023
Q4 | $15.6K | Sell |
20
-25
| -56% | -$19.5K | ﹤0.01% | 5698 |
|
|
2023
Q3 | $80.3K | Sell |
45
-2
| -4% | -$3.57K | ﹤0.01% | 5001 |
|
|
2023
Q2 | $213K | Buy |
47
+14
| +42% | +$63.5K | ﹤0.01% | 4592 |
|
|
2023
Q1 | $170K | Buy |
33
+9
| +38% | +$46.2K | ﹤0.01% | 4975 |
|
|
2022
Q4 | $82.3K | Buy |
24
+5
| +26% | +$17.1K | ﹤0.01% | 5027 |
|
|
2022
Q3 | $148K | Buy |
19
+12
| +171% | +$93.5K | ﹤0.01% | 5034 |
|
|
2022
Q2 | $46K | Sell |
7
-20
| -74% | -$131K | ﹤0.01% | 5255 |
|
|
2022
Q1 | $382K | Sell |
27
-12
| -31% | -$170K | ﹤0.01% | 4054 |
|
|
2021
Q4 | $705K | Buy |
39
+30
| +333% | +$542K | ﹤0.01% | 3331 |
|
|
2021
Q3 | $186K | Buy |
+9
| New | +$186K | ﹤0.01% | 4749 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6024 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$23K | – | 5055 |
|
|
2020
Q1 | $23K | Buy |
+2
| New | +$23K | ﹤0.01% | 4327 |
|
|
2019
Q4 | – | Hold |
0
| – | -$7K | – | 4948 |
|
|
2019
Q3 | – | Hold |
0
| – | -$23K | – | 4357 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4351 |
|
|
2018
Q4 | – | Hold |
0
| – | -$18K | – | 5043 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | -$622K | – | 3191 |
|
|
2018
Q2 | $622K | Buy |
+1
| New | +$622K | ﹤0.01% | 2039 |
|